FBRX Forte Biosciences, Inc. - Common Stock
$76,93
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$10–$77
100% of range
Analystenbewertung
HOLD
11 analysts
Kursziel
$74
P/E (TTM)
-16.3
ROE
-86.9%
Nettogewinnmarge
-2555.2%
FBRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$76.93
Marktkapitalisierung
$996M
P/E (TTM)
-16.3
EPS (TTM)
$-4.71
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-86.9%
Verschuldungsgrad
—
52W-Spanne
$10 – $77
FBRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2016-12-31
→
2019-12-31
EPS
$-4.71
2021-12-31
→
2025-12-31
Freier Cashflow
$-51M
2017-12-31
→
2025-12-31
Margen
-2555.2%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
FBRX
Peer-Median
P/E (TTM)
-16.3
—
P/S (TTM) (K/V (TTM))
55.2
22.4
P/B (K/B)
16.3
2.7
Price / FCF (Kurs / FCF)
-19.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
FBRX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-2602.5%
—
Net Profit Margin (Nettogewinnmarge)
-2555.2%
-638.9%
ROA
-96.1%
-43.1%
ROE
-86.9%
-49.0%
ROIC
-117.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
FBRX
Peer-Median
Current Ratio (Liquiditätsgrad)
3.9
9.0
Quick Ratio
3.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
FBRX
Peer-Median
Revenue YoY (Umsatz YoY)
106.6%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
155.9%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
FBRX
Peer-Median
FBRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
11 Analysten
- Starker Kauf 2 18,2%
- Kauf 4 36,4%
- Halten 5 45,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-13
Median
$77.00
Mittelwert
$73.80
Jetzt
$76.93
Tief
$61.00
Hoch
$77.00
Median-Ziel
$77.00
+0,1%
Mittelwert-Ziel
$73.80
-4,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.07%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.97 | $-0.90 | -0.07% |
| 31. März 2026 | $-1.24 | $-1.22 | -0.02% |
| 31. Dezember 2025 | $-1.39 | $-1.24 | -0.15% |
| 30. September 2025 | $-0.99 | $-1.09 | 0.10% |
| 30. Juni 2025 | $-0.96 | $-1.13 | 0.17% |
| 31. März 2025 | $-1.37 | $-0.97 | -0.40% |
| 31. Dezember 2024 | $-2.45 | $-3.34 | 0.89% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ANAB | — | -105.4 | 157.0% | — | — | — |
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| TRAX | — | — | — | — | — | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| PURR | — | — | — | — | — | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $36.0K | $18M | $41.0K | $49.0K | |
| R&D Expense | · | · | · | · | · | · | $45M | $51M | $29M | $27M | |
| SG&A Expense | $12M | $15M | $11M | $8M | $8M | $4M | $1M | $13M | $9M | $5M | |
| Operating Expenses | $71M | $37M | $32M | $14M | $21M | $46M | $4M | $64M | $38M | $32M | |
| Operating Income | $-71M | $-37M | $-32M | $-14M | $-21M | $-46M | $-4M | $-46M | $-38M | $-32M | |
| Other Non-op | $-396.0K | $-190.0K | $-114.0K | $-145.0K | $-222.0K | $-205.0K | $-5.0K | · | $-1M | $-2M | |
| Pretax Income | $-68M | $-35M | $-31M | · | · | · | $-64M | $-47M | $-39M | $-33M | |
| Income Tax | $1M | $0 | · | · | · | · | $1.0K | $2M | $1.0K | $1.0K | |
| Net Income | $-69M | $-35M | $-31M | $-14M | $-22M | $-46M | $-4M | $-49M | $-39M | $-33M | |
| EPS (Basic) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | · | · | · | · | · | |
| EPS (Diluted) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | · | · | · | · | · | |
| Shares (Basic) | · | · | · | 17,383,531 | 13,967,818 | · | · | · | · | · | |
| Shares (Diluted) | · | · | · | 17,383,531 | 13,967,818 | · | · | · | · | · | |
| EBITDA | $-71M | $-37M | · | · | $-21M | $-46M | · | $-46M | $-38M | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $22M | $37M | $41M | $42M | $59M | $7M | $41M | $36M | $6M | |
| Short-term Investments | $0 | $36M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $3M | $1M | $411.0K | $476.0K | $1M | $567.0K | $2M | $2M | $1M | |
| Current Assets | $81M | $61M | $38M | $42M | $43M | $60M | $8M | $98M | $91M | $32M | |
| PP&E (Net) | $129.0K | $77.0K | $109.0K | · | · | $97.0K | $152.0K | $4M | $1M | $743.0K | |
| PP&E (Gross) | $241.0K | $125.0K | $118.0K | · | · | · | $3M | $7M | $4M | $3M | |
| Accum. Depreciation | $112.0K | $48.0K | $9.0K | · | · | · | $2M | $3M | $3M | $2M | |
| Other Non-current Assets | $2M | $138.0K | $544.0K | $486.0K | $786.0K | $1M | $0 | $1M | $227.0K | $2M | |
| Total Assets | $83M | $62M | $39M | $42M | $43M | $61M | $8M | $103M | $92M | $35M | |
| Accounts Payable | $10M | $5M | $1M | $1M | $946.0K | $1M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $11M | $4M | $2M | $2M | $812.0K | $1M | $343.0K | $13M | $8M | $5M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | $7M | $7M | |
| Current Liabilities | $21M | $9M | $4M | $3M | $2M | $2M | $2M | $17M | $17M | $14M | |
| Capital Leases | · | · | · | · | · | · | $4M | · | · | · | |
| Other Non-current Liabilities | $1M | · | · | · | · | · | $81.0K | · | · | · | |
| Total Liabilities | $22M | $9M | · | · | · | · | $17M | $45M | $21M | $28M | |
| Total Debt | · | · | · | · | · | · | · | $26M | $11M | · | |
| Common Stock | $13.0K | $6.0K | $1.0K | $21.0K | $15.0K | $13.0K | $2.0K | $23.0K | $20.0K | $2.0K | |
| Retained Earnings | $-223M | $-154M | $-119M | $-87M | $-73M | $-51M | $-5M | $-216M | $-167M | $-128M | |
| AOCI | $3.0K | $11.0K | $4.0K | · | · | · | $10.0K | $-23.0K | $-34.0K | · | |
| Stockholders' Equity | $61M | $52M | $35M | $39M | $42M | $59M | $-5M | $-736.0K | $71M | $-124M | |
| Liabilities + Equity | $83M | $62M | $39M | $42M | $43M | $61M | $8M | $103M | $92M | $35M | |
| Shares Outstanding | 12,948,308 | 6,393,323 | 1,453,402 | 21,000,069 | 14,754,447 | 12,830,598 | 2,108,266 | 23,000,151 | 19,882,551 | 2,202,517 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $3M | $3M | $4M | $4M | $956.0K | $36.0K | $7M | $4M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | |
| Operating Cash Flow | $-51M | $-31M | $-29M | $-8M | $-17M | $-18M | $-3M | $-34M | $-31M | $-30M | |
| CapEx | $116.0K | $37.0K | $88.0K | · | · | · | $162.0K | $2M | $655.0K | $525.0K | |
| Investing Cash Flow | $36M | $-36M | $47.0K | · | · | $4M | $-162.0K | $-4M | $-28M | $25M | |
| Stock Issued | $2M | $0 | · | $7M | · | $67M | $551.0K | $661.0K | $507.0K | $10.0K | |
| Net Stock Activity | $2M | · | · | · | · | $67M | · | $661.0K | $507.0K | · | |
| Financing Cash Flow | $69M | $52M | $25M | $7M | $-44.0K | $67M | $5M | $44M | $89M | $2M | |
| Net Change in Cash | $55M | $-15M | $-4M | $-944.0K | $-17M | $52M | $2M | $5M | $30M | $-3M | |
| Free Cash Flow | $-51M | $-31M | · | · | · | · | · | $-36M | $-32M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2602.5% | -2785.5% | · | · | · | · | · | -254.2% | · | · | |
| Net Margin | -2555.2% | -2700.0% | · | · | · | · | · | -271.4% | · | · | |
| Pretax Margin | -2517.1% | -2700.0% | · | · | · | · | · | -262.0% | · | · | |
| EBITDA Margin | -2602.5% | -2785.5% | · | · | · | · | · | -254.2% | · | · | |
| ROA | -96.1% | -70.6% | · | · | -41.5% | -134.9% | · | -50.2% | -61.1% | · | |
| ROE | -86.9% | -114.7% | · | · | -51.0% | -117.2% | · | -92.5% | 146.0% | · | |
| ROIC | -117.6% | · | · | · | · | · | · | -56.3% | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 6.8 | · | · | 24.2 | 26.5 | · | 5.9 | 5.2 | · | |
| Quick Ratio | 3.7 | 6.4 | · | · | 23.9 | 26.0 | · | 2.5 | 2.1 | · | |
| Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.2 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.1 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | 0.2 | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 106.6% | 16.9% | 593.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 155.9% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $18M | $18M | $18M | $18M | $18M | $36.0K | $18M | $41.0K | · | |
| Net Income TTM | $-69M | $-35M | $-31M | $-14M | $-22M | $-46M | $-4M | $-49M | $-39M | · | |
| Market Cap | $353M | $145M | · | · | $789M | $11.68B | · | $70.81B | $76.42B | · | |
| Enterprise Value | · | · | · | · | · | · | · | $70.80B | $76.40B | · | |
| P/E | -5.8 | -1.9 | -0.8 | -31.2 | -34.5 | · | · | · | · | · | |
| P/S | 19.6 | 8.1 | · | · | 43.8 | 647.5 | · | 3926.1 | 1863989.2 | · | |
| P/B | 5.8 | 2.8 | · | · | 19.0 | 198.0 | · | 1217.8 | 1075.1 | · | |
| P / Tangible Book | 5.8 | 2.8 | 21.1 | 13.5 | 19.0 | 198.0 | · | · | · | · | |
| P / Cash Flow | -6.9 | -4.7 | · | · | -47.3 | -633.9 | · | -2054.4 | -2454.7 | · | |
| P / FCF | -6.9 | -4.7 | · | · | · | · | · | -1943.4 | -2404.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | -1544.0 | -2030.3 | · | |
| EV / FCF | · | · | · | · | · | · | · | -1943.0 | -2403.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | 3925.3 | 1863376.8 | · | |
| Earnings Yield | -17.3% | -53.6% | -121.3% | -3.2% | -2.9% | · | · | · | · | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $3M | $7M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $25M | $22M | $25M | $18M | $12M | $16M | $7M | $9M | $13M | $8M | $6M | $10M | $9M | $7M | $5M | $3M | |
| Operating Income | $-25M | $-22M | $-25M | $-18M | $-12M | $-16M | $-7M | $-9M | $-13M | $-8M | $-6M | $-10M | $-9M | $-7M | $-5M | $-3M | |
| Other Non-op | $1M | $676.0K | $-2M | $701.0K | $330.0K | $468.0K | $-1M | $237.0K | $307.0K | $384.0K | $-615.0K | $261.0K | $138.0K | $102.0K | $-100.0K | $23.0K | |
| Pretax Income | $-23M | $-22M | · | · | $-11M | $-16M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $193.0K | $373.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-23M | $-22M | $-25M | $-18M | $-11M | $-16M | $-7M | $-8M | $-13M | $-7M | $-6M | $-10M | $-9M | $-7M | $-5M | $-3M | |
| EPS (Basic) | $-0.97 | $-1.24 | $-1.39 | $-0.99 | $-0.96 | $-1.37 | $3.18 | $-4.54 | $-6.78 | $-4.03 | $-17.61 | $-6.57 | $-0.42 | $-0.32 | $-0.24 | $-0.18 | |
| EPS (Diluted) | $-0.97 | $-1.24 | $-1.39 | $-0.99 | $-0.96 | $-1.37 | $3.18 | $-4.54 | $-6.78 | $-4.03 | $-17.61 | $-6.57 | $-0.42 | $-0.32 | $-0.24 | $-0.18 | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | 21,046,831 | 21,006,680 | · | 18,927,446 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | 21,046,831 | 21,006,680 | · | 18,927,446 | |
| EBITDA | $-25M | $-22M | · | $-18M | $-12M | $-16M | · | $-9M | $-13M | $-8M | · | $-10M | $-9M | $-7M | · | $-3M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $58M | $77M | $93M | $106M | $46M | $22M | $16M | $24M | $30M | $37M | $46M | $20M | $36M | $41M | $44M | |
| Short-term Investments | $149M | · | · | · | · | · | $36M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $7M | $4M | $2M | $1M | $1M | $3M | $1M | $1M | $1M | $1M | $917.0K | $322.0K | $369.0K | $411.0K | $546.0K | |
| Current Assets | $203M | $65M | $81M | $95M | $108M | $47M | $61M | $18M | $26M | $32M | $38M | $47M | $31M | $36M | $42M | $45M | |
| PP&E (Net) | $90.0K | $110.0K | $129.0K | $148.0K | $110.0K | $125.0K | $77.0K | $86.0K | $96.0K | $106.0K | $109.0K | $98.0K | $30.0K | · | · | · | |
| PP&E (Gross) | $241.0K | $241.0K | $241.0K | $241.0K | $186.0K | $186.0K | $125.0K | $124.0K | $124.0K | $124.0K | $118.0K | · | · | · | · | · | |
| Accum. Depreciation | $151.0K | $131.0K | $112.0K | $93.0K | $76.0K | $61.0K | $48.0K | $38.0K | $28.0K | $18.0K | $9.0K | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $2M | $2M | $57.0K | $176.0K | $138.0K | $192.0K | $271.0K | $409.0K | $544.0K | $679.0K | $407.0K | $437.0K | $486.0K | $534.0K | |
| Total Assets | $206M | $67M | $83M | $97M | $108M | $47M | $62M | $18M | $26M | $32M | $39M | $48M | $31M | $37M | $42M | $45M | |
| Accounts Payable | $14M | $13M | $10M | $5M | $5M | $5M | $5M | $5M | $5M | $2M | $1M | $5M | $3M | $1M | $1M | $1M | |
| Accrued Liabilities | $6M | $11M | $11M | $8M | $4M | $4M | $4M | $3M | $4M | $2M | $2M | $2M | $3M | $2M | $2M | $1M | |
| Current Liabilities | $20M | $24M | $21M | $13M | $9M | $9M | $9M | $9M | $9M | $3M | $4M | $7M | $6M | $4M | $3M | $2M | |
| Other Non-current Liabilities | $2M | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $22M | $25M | $22M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $21.0K | $14.0K | $13.0K | $13.0K | $12.0K | $6.0K | $6.0K | $1.0K | $36.0K | $36.0K | $1.0K | $36.0K | $21.0K | $21.0K | $21.0K | $21.0K | |
| Retained Earnings | $-269M | $-246M | $-223M | $-199M | $-181M | $-170M | $-154M | $-147M | $-138M | $-126M | $-119M | $-113M | $-103M | $-94M | $-87M | $-82M | |
| AOCI | $-54.0K | $-4.0K | $3.0K | $-6.0K | · | · | $11.0K | $1.0K | $-7.0K | $-2.0K | $4.0K | $-5.0K | $1.0K | · | · | · | |
| Stockholders' Equity | $184M | $42M | $61M | $84M | $99M | $38M | $52M | $9M | $17M | $29M | $35M | $40M | $25M | $33M | $39M | $43M | |
| Liabilities + Equity | $206M | $67M | $83M | $97M | $108M | $47M | $62M | $18M | $26M | $32M | $39M | $48M | $31M | $37M | $42M | $45M | |
| Shares Outstanding | 20,482,400 | 13,910,668 | 12,948,308 | 12,523,845 | 12,282,024 | 6,581,667 | 6,393,323 | 1,460,007 | 36,442,380 | 36,394,882 | 1,453,402 | 36,281,772 | 21,051,195 | 21,007,069 | 21,000,069 | 21,000,069 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $2M | $1M | $1M | $2M | $697.0K | $791.0K | $802.0K | $805.0K | $780.0K | $772.0K | $855.0K | $877.0K | $860.0K | $906.0K | |
| Operating Cash Flow | $-23M | $-19M | $-16M | $-14M | $-10M | $-10M | $-10M | $-8M | $-6M | $-7M | $-9M | $-9M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $0 | $0 | $0 | $55.0K | $0 | $61.0K | $31.0K | $0 | $0 | $6.0K | $17.0K | · | · | · | · | · | |
| Investing Cash Flow | $-148M | $0 | $0 | $-55.0K | $0 | $36M | $-36M | $0 | $0 | $-6.0K | $-16.0K | $10M | · | · | · | · | |
| Stock Issued | · | · | $0 | $-73M | · | · | · | · | $0 | $8.0K | · | $25M | $0 | $6.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $8.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $162M | $74.0K | $9.0K | $1M | $70M | $-2M | $52M | $-2.0K | $-10.0K | $-8.0K | $-75.0K | $25M | $-24.0K | $6.0K | $-55.0K | $7M | |
| Net Change in Cash | $-9M | $-19M | $-16M | $-13M | $60M | $24M | $6M | $-8M | $-6M | $-7M | $-9M | $26M | $-15M | $-5M | $-3M | $6M | |
| Free Cash Flow | · | $-19M | · | · | · | $-10M | · | · | · | $-7M | · | · | · | · | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.9% | -38.6% | · | -30.7% | -16.8% | -39.4% | · | -25.5% | -43.7% | -21.6% | · | -21.4% | -25.1% | -17.3% | · | -7.3% | |
| ROE | -16.5% | -55.0% | · | -37.8% | -19.5% | -46.7% | · | -33.7% | -59.8% | -24.1% | · | -23.9% | -28.2% | -18.5% | · | -7.9% | |
| ROIC | -13.5% | -54.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 2.8 | · | 7.3 | 11.7 | 5.2 | · | 2.1 | 2.8 | 9.5 | · | 6.3 | 4.9 | 9.6 | · | 19.4 | |
| Quick Ratio | 9.8 | 2.5 | · | 7.2 | 11.6 | 5.1 | · | 1.9 | 2.7 | 9.1 | · | 6.2 | 3.2 | 9.5 | · | 19.2 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | |
| Net Income TTM | $-74M | $-67M | · | $-53M | $-48M | $-44M | · | $-38M | $-39M | $-33M | · | $-29M | $-22M | $-16M | · | $-17M | |
| Market Cap | $435M | $360M | · | $188M | $159M | $51M | · | $8M | $489M | $633M | · | $600M | $547M | $530M | · | $562M | |
| P/E | -5.1 | -5.7 | · | -1.9 | -0.9 | -0.5 | · | -0.3 | -0.8 | -1.5 | · | -2.2 | -23.0 | -28.7 | · | -24.3 | |
| P/S | 24.1 | 20.0 | · | 10.4 | 8.8 | 2.8 | · | 0.5 | 27.1 | 35.1 | · | 33.3 | 30.3 | 29.4 | · | 31.1 | |
| P/B | 2.4 | 8.6 | · | 2.2 | 1.6 | 1.3 | · | 0.9 | 28.8 | 22.1 | · | 14.9 | 22.0 | 16.1 | · | 13.1 | |
| P / Tangible Book | 2.4 | 8.6 | · | 2.2 | 1.6 | 1.3 | · | 0.9 | 28.8 | 22.1 | · | 14.9 | 22.0 | 16.1 | · | 13.1 | |
| P / Cash Flow | · | -19.2 | · | · | · | -4.9 | · | · | · | -95.0 | · | · | · | -101.9 | · | · | |
| P / FCF | · | -19.2 | · | · | · | -4.9 | · | · | · | -94.9 | · | · | · | · | · | · | |
| Earnings Yield | -19.6% | -17.6% | · | -52.4% | -105.6% | -215.5% | · | -392.1% | -132.6% | -65.2% | · | -45.3% | -4.3% | -3.5% | · | -4.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Betriebsgewinnmarge % | -2602.5% | -2785.5% | — | — | — |
| Nettoergebnis | $-69M | $-35M | $-31M | $-14M | $-22M |
| Verwässerte EPS | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.9 | 6.8 | — | — | 24.2 |
| Quick Ratio | 3.7 | 6.4 | — | — | 23.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-51M | $-31M | — | — | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 91 Einreicher · $409.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 34 (+11 vs. Vorquartal) | 13 (+6 vs. Vorquartal) | 30 (+13 vs. Vorquartal) | 16 (-4 vs. Vorquartal) | +4.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FEDERATED HERMES, INC. | $44.848.465 | 2.110.516 | 10,94% | Aktien |
| ORBIMED ADVISORS LLC | $33.526.231 | 1.577.705 | 8,18% | Aktien |
| JANUS HENDERSON GROUP PLC | $30.812.336 | 1.188.060 | 7,52% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $30.593.561 | 1.439.697 | 7,47% | Aktien |
| Affinity Asset Advisors, LLC | $24.339.559 | 1.145.391 | 5,94% | Aktien |
| MPM BIOIMPACT LLC | $20.983.270 | 987.448 | 5,12% | Aktien |
| TCG Crossover Management, LLC | $19.550.000 | 920.000 | 4,77% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $18.311.911 | 861.737 | 4,47% | Aktien |
| Woodline Partners LP | $15.146.001 | 712.753 | 3,70% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $14.875.000 | 700.000 | 3,63% | Aktien |
| Integral Health Asset Management, LLC | $14.343.750 | 675.000 | 3,50% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $13.922.979 | 655.199 | 3,40% | Aktien |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $11.799.705 | 786.647 | 2,88% | Aktien |
| CITADEL ADVISORS LLC | $11.388.789 | 535.943 | 2,78% | Aktien |
| FMR LLC | $10.685.053 | 502.826 | 2,61% | Aktien |
| AMERIPRISE FINANCIAL INC | $8.898.586 | 418.757 | 2,17% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $8.502.392 | 400.003 | 2,07% | Aktien |
| Cable Car Capital, LP | $8.500.000 | 400.000 | 2,07% | Aktien |
| STATE STREET CORP | $6.981.093 | 328.522 | 1,70% | Aktien |
| Candriam S.C.A. | $6.434.678 | 303.100 | 1,57% | Aktien |
| Boxer Capital Management, LLC | $5.833.125 | 274.500 | 1,42% | Aktien |
| Trails Edge Capital Partners, LP | $5.805.097 | 273.181 | 1,42% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $5.305.976 | 249.693 | 1,29% | Aktien |
| Squadron Capital Management LLC | $4.781.250 | 225.000 | 1,17% | Aktien |
| AWM Investment Company, Inc. | $4.728.125 | 222.500 | 1,15% | Aktien |
| UBS Group AG | $3.463.198 | 162.974 | 0,85% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.893.698 | 136.174 | 0,71% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.842.634 | 133.771 | 0,69% | Aktien |
| Nuveen, LLC | $2.302.374 | 108.347 | 0,56% | Aktien |
| VANGUARD GROUP INC | $1.842.770 | 67.575 | 0,45% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.797.750 | 84.600 | 0,44% | Verkaufsoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $999.664 | 47.043 | 0,24% | Aktien |
| J. Goldman & Co LP | $981.368 | 46.182 | 0,24% | Aktien |
| Balyasny Asset Management L.P. | $826.583 | 38.898 | 0,20% | Aktien |
| MANGROVE PARTNERS IM, LLC | $708.603 | 33.346 | 0,17% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $639.795 | 30.108 | 0,16% | Aktien |
| XTX Topco Ltd | $636.374 | 29.947 | 0,16% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $559.470 | 26.328 | 0,14% | Aktien |
| Trexquant Investment LP | $534.820 | 25.168 | 0,13% | Aktien |
| Weil Company, Inc. | $526.256 | 24.765 | 0,13% | Aktien |
| AlphaQuest LLC | $512.785 | 18.804 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $470.662 | 22.149 | 0,11% | Aktien |
| Ikarian Capital, LLC | $445.655 | 20.972 | 0,11% | Aktien |
| JANE STREET GROUP, LLC | $418.370 | 19.688 | 0,10% | Aktien |
| Persistent Asset Partners Ltd | $388.089 | 18.263 | 0,09% | Aktien |
| WELLS FARGO & COMPANY/MN | $375.360 | 17.664 | 0,09% | Aktien |
| Russell Investments Group, Ltd. | $349.180 | 16.432 | 0,09% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $346.162 | 16.290 | 0,08% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304.109 | 14.311 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $293.250 | 13.800 | 0,07% | Kaufoption |
| TWO SIGMA INVESTMENTS, LP | $284.984 | 13.411 | 0,07% | Aktien |
| Squarepoint Ops LLC | $261.736 | 12.317 | 0,06% | Aktien |
| BANK OF AMERICA CORP /DE/ | $251.345 | 11.828 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $243.759 | 11.471 | 0,06% | Aktien |
| Bank of New York Mellon Corp | $237.958 | 11.198 | 0,06% | Aktien |
| GOLDMAN SACHS GROUP INC | $236.576 | 11.133 | 0,06% | Aktien |
| BlackRock, Inc. | $218.153 | 10.266 | 0,05% | Aktien |
| ExodusPoint Capital Management, LP | $217.239 | 10.223 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $188.700 | 8.880 | 0,05% | Aktien |
| China Universal Asset Management Co., Ltd. | $170.000 | 8.000 | 0,04% | Aktien |
| CITIGROUP INC | $169.660 | 7.984 | 0,04% | Aktien |
| Invesco Ltd. | $164.114 | 7.723 | 0,04% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $144.500 | 6.800 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $142.418 | 6.702 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $121.380 | 5.712 | 0,03% | Aktien |
| NORTHERN TRUST CORP | $64.558 | 3.038 | 0,02% | Aktien |
| BARCLAYS PLC | $58.438 | 2.750 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $45.475 | 2.140 | 0,01% | Aktien |
| Legal & General Group Plc | $39.950 | 1.880 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $37.358 | 1.758 | 0,01% | Aktien |
| STRS OHIO | $36.125 | 1.700 | 0,01% | Aktien |
| Quantbot Technologies LP | $30.685 | 1.444 | 0,01% | Aktien |
| State of Wyoming | $21.675 | 1.020 | 0,01% | Aktien |
| ROYAL BANK OF CANADA | $16.000 | 748 | 0,00% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $12.155 | 572 | 0,00% | Aktien |
| Steward Partners Investment Advisory, LLC | $10.476 | 493 | 0,00% | Aktien |
| DEUTSCHE BANK AG\ | $7.884 | 371 | 0,00% | Aktien |
| LORD, ABBETT & CO. LLC | $4.472 | 210.442 | 0,00% | Aktien |
| COMERICA BANK | $4.091 | 150 | 0,00% | Aktien |
| FIFTH THIRD BANCORP | $3.188 | 150 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $2.401 | 113 | 0,00% | Aktien |
| GROUP ONE TRADING LLC | $2.210 | 104 | 0,00% | Aktien |
| Sterling Capital Management LLC | $1.445 | 68 | 0,00% | Aktien |
| MORGAN STANLEY | $829 | 39 | 0,00% | Aktien |
| ASSETMARK, INC | $723 | 34 | 0,00% | Aktien |
| Quarry LP | $574 | 27 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $338 | 15.900 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $256 | 12 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $255 | 12 | 0,00% | Aktien |
| REAP Financial Group, LLC | $64 | 3 | 0,00% | Aktien |
| Allworth Financial LP | $22 | 1 | 0,00% | Aktien |
Unternehmensinsider 26 Insider · 9 Führungskräfte · 19 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul A. Wagner | CEO, Secretary and Chair of the Board | 1. Juli 2026 M | 85.482 | 0 | 0 | $0 |
| Martin J Duvall | Chief Executive Officer | 4. Oktober 2019 A | 13.605 | 0 | 0 | $0 |
| Antony A Riley | CHIEF FINANCIAL OFFICER | 1. Juli 2026 M | 42.600 | 1 | 0 | $254.874 |
| Mark G Foletta | EVP & Chief Financial Officer | 4. Oktober 2019 A | 15.042 | 0 | 0 | $0 |
| Hubert C Chen | President and Chief Scientific Officer | 1. Januar 2024 M | 93.405 | 0 | 0 | $0 |
| Harry E Gruber | President, Science&Innovation | 26. Februar 2020 A | 23.685 | 0 | 0 | $0 |
| Fairooz Kabbinavar | SVP Clinical Development | 4. Oktober 2019 A | — | 0 | 0 | $0 |
| Douglas Jolly | EVP, Research & Pharm Devel | 4. Oktober 2019 A | 393.478 | 0 | 0 | $0 |
| Asha Das | SVP & Chief Medical Officer | 1. März 2018 A | 5.000 | 0 | 0 | $0 |
| Shivpreet Singh Kapoor | Direktor | 29. Mai 2026 A | — | 0 | 0 | $0 |
| Scott C. Brun | Direktor | 29. Mai 2026 A | — | 0 | 0 | $0 |
| Steven Kornfeld | Direktor | 29. Mai 2026 A | 99.009 | 0 | 0 | $0 |
| Stephen K Doberstein | Direktor | 29. Mai 2026 A | — | 0 | 0 | $0 |
| Richard G Vincent | Direktor | 29. Mai 2026 A | — | 0 | 0 | $0 |
| David W Gryska | Direktor | 29. Mai 2026 A | 148.514 | 0 | 0 | $0 |
| Lawrence Eichenfield | Direktor | 19. September 2023 A | — | 0 | 0 | $0 |
| Donald Allen Williams | Direktor | 19. September 2023 A | 59.405 | 0 | 0 | $0 |
| Barbara K Finck | Direktor | 19. September 2023 A | — | 0 | 0 | $0 |
| Patricia S Walker | Direktor | 1. Juni 2022 A | — | 0 | 0 | $0 |
| Thomas E Darcy | Direktor | 13. Januar 2021 M | 2.358 | 0 | 0 | $0 |
| Lori Anne Kunkel | Direktor | 4. Oktober 2019 A | — | 0 | 0 | $0 |
| David Ross Parkinson | Direktor | 4. Oktober 2019 A | — | 0 | 0 | $0 |
| Faheem Hasnain | Direktor | 4. Oktober 2019 A | 245.857 | 0 | 0 | $0 |
| Franklin M Berger | Direktor | 4. Oktober 2019 A | 25.335 | 0 | 0 | $0 |
| SCHIMMEL PAUL | Direktor | 4. Oktober 2019 A | 13.623 | 0 | 0 | $0 |
| Steven Michael Oliveira | 10%-Eigentümer | 14. April 2020 P | 2.873.450 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, Eric Shahinian, ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg, Michael G. Hacke, McIntyre Partnerships, LP, McIntyre Capital GP, LLC, McIntyre Capital Management, LP, McIntyre Capital Management GP, LLC, Chris McIntyre ×11 Einreichungen | 17. Juni 2024 | — | Erste Einreichung | Vorstandskampagne | SEC |
| BML Investment Partners, L.P. ×6 Einreichungen | 11. Januar 2024 | — | Erste Einreichung | Passive Anlage | SEC |
| Funicular Funds, LP, Jacob Ma-Weaver ×6 Einreichungen | 9. Januar 2024 | — | Erste Einreichung | — | SEC |
| Paul A. Wagner, Ph.D. (2) ×2 Einreichungen | 15. August 2023 | — | Erste Einreichung | — | SEC |
| ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg ×2 Einreichungen | 10. August 2023 | — | Erste Einreichung | — | SEC |
| Paul A. Wagner, Ph.D. | 25. Juni 2020 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 13 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,15% | 12.912 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1.062 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| ITOT · iShares Trust | — | — | 22. Juli 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWO · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13. Juli 2026 | Täglich |